Document is current

Any future updates will be listed below

Efficacy and safety of anlotinib combined with immune checkpoint inhibitors in the treatment of extensive-stage small cell lung cancer: a meta-analysis based on real-world data

Crossref DOI link: https://doi.org/10.1186/s12890-025-04018-9

Published Online: 2025-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark